Wegovy is first GLP-1 treatment approved for MASH FDA decision based on part one of an ongoing study Novo Nordisk seeks approval in Europe and Japan Aug 15 (Reuters) - Novo Nordisk (NOVOb.CO), opens ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback